v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Common Stock
Preferred Stock (Series C)
Additional Paid-in Capital
Common Stock to be Issued
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 2,708 $ 11,745,436 $ (10,562,799) $ 1,185,345
Balance (in Shares) at Dec. 31, 2024 27,080,915          
Share-based compensation 495,500 495,500
Issuance of shares for note payable conversions $ 143 466,026 466,169
Issuance of shares for note payable conversions (in Shares) 1,429,717          
Issuance of equity warrants in connection with convertible debt 679,577 679,577
Termination of shares issued during merger under FPA agreement 46,100 46,100
Net loss (2,116,726) (2,116,726)
Balance at Mar. 31, 2025 $ 2,851 13,432,639 (12,679,525) 755,965
Balance (in Shares) at Mar. 31, 2025 28,510,632          
Balance at Dec. 31, 2025 $ 7,254 30,054,695 516,000 (21,114,473) 9,463,476
Balance (in Shares) at Dec. 31, 2025 72,536,722          
Share-based compensation employee $ 500 2,085,430 2,085,930
Share-based compensation employee (in Shares) 5,000,000          
Share-based compensation-non-employee $ 915 3,536,554 (516,000) 3,021,469
Share-based compensation-non-employee (in Shares) 9,150,000          
Termination of shares issued during merger under FPA agreement 412,329 412,329
Issuance of Preferred B stock for cash $ 5 47,939,995 47,940,000
Issuance of Preferred B stock for cash (in Shares)   47,940        
Issuance of common shares $ 3,455 2,399,104 2,402,559
Issuance of common shares (in Shares) 34,551,938          
Net loss (13,857,203) (13,857,203)
Balance at Mar. 31, 2026 $ 12,124 $ 5 $ 86,428,107 $ (34,971,676) $ 51,468,560
Balance (in Shares) at Mar. 31, 2026 121,238,660 47,940